Utrecht, Netherlands

Pieter C Verveer


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Pieter C. Verveer

Introduction

Pieter C. Verveer is a prominent inventor based in Utrecht, Netherlands. Known for his contributions to the field of pharmaceuticals, he has made significant strides in the development of innovative compounds.

Latest Patents

Verveer holds a patent for a novel compound titled 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7H-pyrrolo[2,3d]pyrimidine hydrogen mesylate, which includes its polymorphic forms. This invention not only introduces a new compound but also outlines methods for its production. The polymorphic forms of the compound, namely α and β, add versatility to its application and potential use in various pharmaceutical contexts.

Career Highlights

Currently, Pieter C. Verveer is associated with Solvay Pharmaceuticals B.V., where he applies his expertise in the pharmaceutical industry. His work there emphasizes the importance of innovation in developing new and effective medications.

Collaborations

Throughout his career, Verveer has collaborated with notable colleagues, including Axel Pahl and Timo Heinrich. These partnerships highlight the importance of teamwork in advancing scientific research and innovation in the pharmaceutical domain.

Conclusion

Pieter C. Verveer's contributions through his patented innovations demonstrate the vital role inventors play in developing new solutions within the pharmaceutical industry. His work at Solvay Pharmaceuticals B.V. and collaborations with fellow researchers illustrate the collective effort needed to drive innovation forward. With his continued dedication, Verveer is sure to make more significant impacts in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…